The DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.
Limitations of reverse-transcriptase polymerase chain reaction analyses for detection of micrometastatic epithelial cancer cells in bone marrow.
Abstract
PURPOSE: This study was designed to evaluate the potential of reverse-transcriptase polymerase chain reaction (RT-PCR) analyses for the detection of micrometastatic carcinoma cells in bone marrow (BM). PATIENTS AND METHODS: The specificity of RT-PCR assays with primers specific for various tumor-associated and organ-specific mRNA species was examined by analysis of 53 BM aspirates from control patients with no epithelial malignancy. In addition, BM samples from 63 patients with prostate cancer (n = 53) or breast cancer (n = 10) were analyzed by RT-PCR with primers specific for prostate-specific antigen (PSA) mRNA. As a reference method, all samples were analyzed simultaneously by an established immunocytochemical assay, using monoclonal antibodies (mAbs) against cytokeratins (CK) for tumor-cell detection. RESULTS: Seven of eight marker species could be detected in a considerable number of BM samples from control patients: epithelial glycoprotein-40 (EGP-40; 53 of 53 samples), desmoplakin I (DPI I; five of five), carcinoembryonic antigen (CEA; five of 19), erb-B2 (five of seven), erb-B3 (six of seven), prostate-specific membrane antigen (PSM; four of nine), and CK18 (five of seven). Only PSA mRNA was not detected in any of the 53 control BM samples. In serial dilution experiments, the PSA RT-PCR assay was able to detect five LNCaP prostate carcinoma cells in 4 x 10(6) BM cells. CK-positive cells were found in 20 patients (37.7%) with prostate cancer, while PSA mRNA was found in only 15 (28.3%; P = .04). Moreover, despite the recent observation that PSA is also expressed in mammary carcinomas, none of the 10 CK-positive BM samples were PSA mRNA-positive. CONCLUSION: Limiting factors in the detection of micrometastatic tumor cells by RT-PCR are (1) the illegitimate transcription of tumor-associated or epithelial-specific genes in hematopoietic cells, and (2) the deficient expression of the marker gene in micrometastatic tumor cells.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction
Chomczynski, P., & Sacchi, N. (1987) · Analytical Biochemistry · doi:10.1016/0003-2697(87)90021-2 · Cited by 46,426
Liotta, L. A., Kleinerman, J. I., & Saidel, G. M. (1974) · PubMed · Cited by 766
Illegitimate transcription: transcription of any gene in any cell type.
Chelly, J., Concordet, J. P., Kaplan, J. C., & Kahn, A. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.8.2617 · Cited by 629
Prognostic significance of micrometastatic tumour cells in bone marrow of colorectal cancer patients
Lindemann, F., Witte, J., Schlimok, G., Dirschedl, P., & Riethmuller, G. (1992) · The Lancet · doi:10.1016/0140-6736(92)92230-d · Cited by 544
Self-citationEp-CAM: a human epithelial antigen is a homophilic cell-cell adhesion molecule.
Litvinov, S. V., Velders, M. P., Bakker, H. A., Fleuren, G. J., & Warnaar, S. O. (1994) · The Journal of cell biology · doi:10.1083/jcb.125.2.437 · Cited by 524
Pantel, K., Schlimok, G., Braun, S., Kutter, D., Lindemann, F., Schaller, G., Funke, I., Izbicki, J. R., & Riethmuller, G. (1993) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/85.17.1419 · Cited by 503
Self-citationCote, R. J., Rosen, P. P., Lesser, M. L., Old, L. J., & Osborne, M. P. (1991) · Journal of Clinical Oncology · doi:10.1200/jco.1991.9.10.1749 · Cited by 435
Sensitive detection of occult breast cancer by the reverse-transcriptase polymerase chain reaction.
Datta, Y. H., Adams, P. T., Drobyski, W. R., Ethier, S. P., Terry, V. H., & Roth, M. S. (1994) · Journal of Clinical Oncology · doi:10.1200/jco.1994.12.3.475 · Cited by 422
Recent Cancer Trends in the United States
Devesa, S. S., Blot, W. J., Stone, B. J., Miller, B. A., Tarone, R. E., & Fraumeni, J. F. (1995) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/87.3.175 · Cited by 420
Gerhard, M., Juhl, H., Kalthoff, H., Schreiber, H. W., Wagener, C., & Neumaier, M. (1994) · Journal of Clinical Oncology · doi:10.1200/jco.1994.12.4.725 · Cited by 373
Pantel, K., Schlimok, G., Angstwurm, M., et al. (1994) · Journal of Hematotherapy · doi:10.1089/scd.1.1994.3.165 · Cited by 306
Self-citationSchlimok, G., Funke, I., Holzmann, B., Göttlinger, G., Schmidt, G., Häuser, H., Swierkot, S., Warnecke, H. H., Schneider, B., Koprowski, H., et al. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.23.8672 · Cited by 299
Self-citationIsraeli, R., Miller, W. H., Su, S. L., et al. (1994) · PubMed · Cited by 233
Yu, H., Diamandis, E. P., & Sutherland, D. J. A. (1994) · Clinical Biochemistry · doi:10.1016/0009-9120(94)90015-9 · Cited by 190
Prognostic significance of bone marrow micrometastases in patients with gastric cancer.
Jauch, K. W., Heiss, M. M., Gruetzner, U., Funke, I., Pantel, K., Babic, R., Eissner, H. J., Riethmueller, G., & Schildberg, F. W. (1996) · Journal of Clinical Oncology · doi:10.1200/jco.1996.14.6.1810 · Cited by 189
Self-citationKrismann, M., Todt, B., Schröder, J., Gareis, D., Müller, K. M., Seeber, S., & Schütte, J. (1995) · Journal of Clinical Oncology · doi:10.1200/jco.1995.13.11.2769 · Cited by 188
Detection of circulating tumor cells in men with localized prostate cancer.
Seiden, M. V., Kantoff, P. W., Krithivas, K., Propert, K., Bryant, M., Haltom, E., Gaynes, L., Kaplan, I., Bubley, G., & DeWolf, W. (1994) · Journal of Clinical Oncology · doi:10.1200/jco.1994.12.12.2634 · Cited by 164
The type I growth factor receptors in human breast cancer
Rajkumar, T., & Gullick, W. J. (1994) · Breast Cancer Research and Treatment · doi:10.1007/bf00666177 · Cited by 123
Molecular characterization of prostate-specific antigen messenger RNA expressed in breast tumors.
Monne, M. I., Croce, C. M., Yu, H., & Diamandis, E. P. (1994) · PubMed · Cited by 97
Molecular cloning and characterization of novel prostate antigen cDNA's
Riegman, P. H. J., Klaassen, P., van der Korput, J. A. G. M., Romijn, J. C., & Trapman, J. (1988) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(88)81066-0 · Cited by 96
Riesenberg, R., Oberneder, R., Kriegmair, M., et al. (1993) · Histochemistry · doi:10.1007/bf00268022 · Cited by 91
Self-citationWood, D. P., Banks, E. R., Humphreys, S., & Rangnekar, V. M. (1994) · Journal of Histochemistry & Cytochemistry · doi:10.1177/42.4.7510319 · Cited by 59
Serum and urine beta---2-microglobulin in hemophagocytic syndrome
Hibi, S., Imashuku, S., Ikushima, S., Fujiwara, F., Hashida, T., Tsunamoto, K., & Todo, S. (1995) · Cancer · doi:10.1002/1097-0142(19950401)75:7<1642::aid-cncr2820750714>3.0.co;2-1 · Cited by 38
Shuldiner, A. R., Nirula, A., & Roth, J. (1990) · Gene · doi:10.1016/0378-1119(90)90176-r · Cited by 28
Cited by
Bustin, S. (2000) · Journal of Molecular Endocrinology · doi:10.1677/jme.0.0250169 · Cited by 3,872
Riethdorf, S., Fritsche, H., Müller, V., Rau, T., Schindlbeck, C., Rack, B., Janni, W., Coith, C., Beck, K., Jänicke, F., et al. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-1695 · Cited by 1,338
Self-citationChallenges in circulating tumour cell research
Alix-Panabières, C., & Pantel, K. (2014) · Nature Reviews Cancer · doi:10.1038/nrc3820 · Cited by 1,300
Self-citationDissecting the metastatic cascade
Pantel, K., & Brakenhoff, R. H. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1370 · Cited by 1,281
Self-citationEmerging molecular markers of cancer
Sidransky, D. (2002) · Nature Reviews Cancer · doi:10.1038/nrc755 · Cited by 662
Metadata
- Authors
- Zippelius, A., Kufer, P., Honold, G., Köllermann, M. W., Oberneder, R., Schlimok, G., Riethmüller, G., & Pantel, K.
- Venue
- Journal of Clinical Oncology
- Published
- 1997-07
- Volume
- 15
- Issue
- 7
- Pages
- 2701-2708
- ISSN
- 0732-183X (ISSN-L)
- 1527-7755
- OpenAlex
- W1834558432
- Cited by
- 277
- References
- 25
- FWCI
- 9.45
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.